First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation

Authors:
  • BBBart De Boeck
    Bart De Boeck
  • MBMiriam Brinkert
    Miriam Brinkert
  • RBRalf Buhmann
    Ralf Buhmann
  • MBMatthias Bossard
    Matthias Bossard
  • RKRichard Kobza
    Richard Kobza
  • FCFlorim Cuculi
    Florim Cuculi

Abstract
Here we describe the first implantation of the novel bicavally anchored Tricento transcatheter heart valve via the transvenous transfemoral access in a 74-year-old woman with severe tricuspid regurgitation and holosystolic hepatic vein backflow. Following successful implantation, caval vein regurgitant volume was reduced leading to symptomatic and clinical improvement at three-month follow-up. The Tricento device represents a promising, novel therapeutic option for patients with severe tricuspid regurgitation who are not candidates for open heart surgery.